Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09CA03	VIOSTAN 40	G	Valsartan - 40mg	40mg	Tablet, film coated	526,786 L.L
C09CA08	VOTUM	B	Olmesartan medoxomil - 40mg	40mg	Tablet, film coated	1,032,071 L.L
C09CA08	VOTUM	B	Olmesartan medoxomil - 40mg	40mg	Tablet, film coated	1,032,071 L.L
C10AA01	VASCOR	G	Simvastatin - 40mg	40mg	Tablet, scored	284,127 L.L
J05AB14	VALCYTE	B	Valganciclovir (HCl) - 450mg	450mg	Tablet, film coated	63,612,039 L.L
J05AB14	VAGLONAX	G	Valganciclovir (HCl) - 450mg	450mg	Tablet, film coated	49,858,549 L.L
J05AB14	VALGANCICLOVIR ARROW	G	Valganciclovir (HCl) - 450mg	450mg	Tablet, coated	46,063,879 L.L
A04AA01	VOMITRON	G	Ondansetron (HCl) - 4mg/5ml	4mg/5ml	Solution	858,779 L.L
A04AA01	VOMITRON	G	Ondansetron (HCl) - 4mg/5ml	4mg/5ml	Solution	304,604 L.L
D04AB01	VERSATIS	B	Lidocaine - 5%	5%	Patch	13,085,712 L.L
D04AB01	VERSATIS	B	Lidocaine - 5%	5%	Patch	2,772,347 L.L
N03AG01	VALPROATE DE SODIUM ARROW LP	G	Sodium valproate - 500mg	500mg	Tablet, coated, scored, prolonged release	253,986 L.L
P02CA01	VERMOX	B	Mebendazole - 500mg	500mg	Tablet	106,164 L.L
J01MA12	VOLCIDIN	G	Levofloxacin (hemihydrate) - 500mg	500mg	Tablet	849,820 L.L
J01XA01	VANCO MEDIS 500MG	G	Vancomycin - 500mg	500mg	Injectable powder for solution	998,475 L.L
J01XA01	VANCOMYCIN HIKMA	G	Vancomycin (HCl) - 500mg	500mg	Injectable powder for solution	998,475 L.L
J01XA01	VANCOMYCINE VIATRIS 500MG	G	Vancomycin - 500mg	500mg	Injectable dry powder for solution	885,115 L.L
J01XA01	VANCOTEN	G	Vancomycin (HCl) - 500mg	500mg	Injectable powder for solution	537,537 L.L
J01XA01	VOXIN	G	Vancomycin (HCl) - 500mg	500mg	Injectable powder for solution	546,944 L.L
J05AB11	VALTREX	B	Valaciclovir - 500mg	500mg	Tablet, film coated	1,126,140 L.L
J05AB11	VALTREX	B	Valaciclovir - 500mg	500mg	Tablet, film coated	4,402,428 L.L
J05AB11	VALACICLOVIR ARROW	G	Valaciclovir - 500mg	500mg	Tablet, film coated, breakable	753,896 L.L
J05AB11	VALACICLOVIR ARROW	G	Valaciclovir - 500mg	500mg	Tablet, film coated, breakable	2,889,261 L.L
J05AB11	VALCYK BENTA	G	Valaciclovir - 500mg	500mg	Tablet, film coated	4,318,214 L.L
J05AB11	VALCYK BENTA	G	Valaciclovir - 500mg	500mg	Tablet, film coated	945,809 L.L
J01MA12	VLOFINOX	G	Levofloxacin (hemihydrate) - 500mg/100ml	500mg/100ml	Injectable solution	814,369 L.L
A11GA01	VITAMIN C S.A.L.F.	G	Ascorbic acid (vit C) - 500mg/5ml	500mg/5ml	Injectable solution	498,566 L.L
M01AB05	VOLTFAST	B	Diclofenac potassium - 50mg	50mg	Powder for solution	165,293 L.L
M01AB05	VOLTFAST	B	Diclofenac potassium - 50mg	50mg	Powder for solution	545,600 L.L
A10BH02	VILDAVITAE	G	Vildagliptin - 50mg	50mg	Tablet	665,202 L.L

...